Transient inflammatory reaction during lenalidomide plus reduced-dose dexamethasone therapy in two patients with relapsed multiple myeloma

Shuji Ozaki; Takeshi Harada; Shiro Fujii; Shingen Nakamura; Hirokazu Miki; Ayako Nakano; Kumiko Kagawa; Kyoko Takeuchi; Masahiro Abe; Toshio Matsumoto

doi:10.1007/s12185-011-0775-1

Transient inflammatory reaction during lenalidomide plus reduced-dose dexamethasone therapy in two patients with relapsed multiple myeloma

Int J Hematol. 2011 Feb;93(2):257-259. doi: 10.1007/s12185-011-0775-1. Epub 2011 Feb 1.

Authors

Shuji Ozaki^{1

2

3}, Takeshi Harada^{4

5}, Shiro Fujii^{4

5}, Shingen Nakamura^{4

5}, Hirokazu Miki^{4

5}, Ayako Nakano^{4

5}, Kumiko Kagawa^{4

5}, Kyoko Takeuchi^{4

5}, Masahiro Abe^{4

5}, Toshio Matsumoto^{4

6}

Affiliations

¹ Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of Health Biosciences, 3-18-15 Kuramoto, Tokushima, 770-8503, Japan. [email protected].
² Department of Hematology, Tokushima University Hospital, Tokushima, Japan. [email protected].
³ Division of Transfusion Medicine, Tokushima University Hospital, Tokushima, Japan. [email protected].
⁴ Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of Health Biosciences, 3-18-15 Kuramoto, Tokushima, 770-8503, Japan.
⁵ Department of Hematology, Tokushima University Hospital, Tokushima, Japan.
⁶ Division of Transfusion Medicine, Tokushima University Hospital, Tokushima, Japan.

PMID: 21279817
DOI: 10.1007/s12185-011-0775-1

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents / administration & dosage
Antineoplastic Agents / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Dexamethasone / administration & dosage
Dexamethasone / therapeutic use*
Humans
Inflammation Mediators / blood*
Lenalidomide
Male
Middle Aged
Multiple Myeloma / blood
Multiple Myeloma / drug therapy*
Multiple Myeloma / immunology
Recurrence
Thalidomide / administration & dosage
Thalidomide / analogs & derivatives*
Thalidomide / therapeutic use

Substances

Antineoplastic Agents
Inflammation Mediators
Thalidomide
Dexamethasone
Lenalidomide